ClinConnect ClinConnect Logo
Search / Trial NCT01541410

Evaluation of the Vascutek Hybrid Graft for Use in the Replacement of the Aortic Arch and Concomitant Treatment of an Aneurysm/Dissection of the Descending Aorta in the Frozen Elephant Trunk Procedure

Launched by VASCUTEK LTD. · Feb 23, 2012

Trial Information

Current as of May 09, 2025

Completed

Keywords

ClinConnect Summary

The Vascutek Hybrid device is designed for use during a frozen elephant trunk procedure. Each system is comprised of a fully sealed traditional prosthesis which is stented at the distal end. A minimum of 10 and a maximum of 30 patients with aneurysmal disease of the ascending aorta, the arch and the proximal descending aorta will receive a hybrid prosthesis implanted without the use of the delivery system and a minimum of 10 patients and a maximum of 20 patients will be implanted with a hybrid device using the delivery system.

The traditional prosthesis component is representative of curre...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with aneurysm and/or dissection of the aortic arch and/or descending aorta
  • 2. Patient must have agreed to participate voluntarily and have signed and dated an Ethics Committee approved Patient Informed Consent
  • 3. Patient is able and willing to comply with the protocol and associated follow-up requirements
  • Exclusion Criteria:
  • 1. Patients unfit for open surgical repair involving circulatory arrest
  • 2. Endocarditis or active infective disorder of the aorta
  • 3. Patients unwilling to give informed consent

About Vascutek Ltd.

Vascutek Ltd. is a leading medical device company specializing in the development and manufacturing of innovative vascular grafts and associated technologies. With a commitment to advancing patient care, Vascutek is dedicated to providing high-quality, reliable solutions for the treatment of vascular diseases. The company's extensive expertise in biomaterials and surgical techniques underpins its clinical trials aimed at evaluating the safety and efficacy of its products. Vascutek's mission is to enhance surgical outcomes and improve the quality of life for patients worldwide through rigorous research, collaboration, and adherence to the highest standards of regulatory compliance.

Locations

Hannover, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials